Literature DB >> 19776335

Progranulin and beta-amyloid distribution: a case report of the brain from preclinical PS-1 mutation carrier.

Gediminas Gliebus1, Andrea Rosso, Carol F Lippa.   

Abstract

BACKGROUND: Progranulin (PGRN) is a multifunctional growth factor that is found in many tissues. Mutations in the PGRN gene cause familial frontotemporal dementia with ubiquitin-positive inclusions. PGRN plaque-like structures have been described in Alzheimer's disease (AD), in association with beta-amyloid (Abeta) plaques.
OBJECTIVE: To investigate PGRN and aggregated Abeta immunolabeling distribution in autopsied brain tissue from the participant with confirmed PS-1 (A246E) mutation, who died prior to clinical symptom onset.
RESULTS: Immunolabeling for PGRN was positive and accumulated/formed plaque-like structures in all studied regions. These structures most frequently colocalized with Abeta though there were some that did not. PGRN plaques were most dense in medial temporal and frontal regions and predominated over aggregated Abeta.
CONCLUSIONS: This case report illustrates PGRN accumulation and Abeta aggregation in preclinical PS-1 AD case and raises the question whether this phenomenon coincides with or precedes Abeta aggregation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776335     DOI: 10.1177/1533317509346209

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  11 in total

1.  Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques.

Authors:  Swetha Gowrishankar; Peng Yuan; Yumei Wu; Matthew Schrag; Summer Paradise; Jaime Grutzendler; Pietro De Camilli; Shawn M Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

2.  Progranulin is a chemoattractant for microglia and stimulates their endocytic activity.

Authors:  Fiona Pickford; Jacob Marcus; Luiz Miguel Camargo; Qiurong Xiao; Danielle Graham; Jan-Rung Mo; Matthew Burkhardt; Vinayak Kulkarni; Jamie Crispino; Heike Hering; Michael Hutton
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 3.  The Role of PGRN in Alzheimer's Disease.

Authors:  Hua Jing; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2015-07-28       Impact factor: 5.590

Review 4.  Mechanisms of granulin deficiency: lessons from cellular and animal models.

Authors:  Gernot Kleinberger; Anja Capell; Christian Haass; Christine Van Broeckhoven
Journal:  Mol Neurobiol       Date:  2012-12-13       Impact factor: 5.590

5.  Recent insights into the involvement of progranulin in frontotemporal dementia.

Authors:  Li Sun; Jason L Eriksen
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

6.  Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models.

Authors:  S Sakura Minami; Sang-Won Min; Grietje Krabbe; Chao Wang; Yungui Zhou; Rustam Asgarov; Yaqiao Li; Lauren H Martens; Lisa P Elia; Michael E Ward; Lennart Mucke; Robert V Farese; Li Gan
Journal:  Nat Med       Date:  2014-09-28       Impact factor: 53.440

Review 7.  Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases.

Authors:  Anarmaa Mendsaikhan; Ikuo Tooyama; Douglas G Walker
Journal:  Cells       Date:  2019-03-11       Impact factor: 6.600

Review 8.  The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia.

Authors:  Elisa Ridolfi; Cinzia Barone; Elio Scarpini; Daniela Galimberti
Journal:  Clin Dev Immunol       Date:  2013-07-18

9.  Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology.

Authors:  Anarmaa Mendsaikhan; Ikuo Tooyama; Jean-Pierre Bellier; Geidy E Serrano; Lucia I Sue; Lih-Fen Lue; Thomas G Beach; Douglas G Walker
Journal:  Acta Neuropathol Commun       Date:  2019-12-21       Impact factor: 7.801

Review 10.  Secreted Chaperones in Neurodegeneration.

Authors:  Kriti Chaplot; Timothy S Jarvela; Iris Lindberg
Journal:  Front Aging Neurosci       Date:  2020-08-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.